Table 4.
ASI Drug Use, Medical and Psychological Composite Scores for the 225 randomized (179 SC group and 72 TAU group) participants at community-based substance abuse treatment programs. *
| Treatment Group | SC | TAU | |
|---|---|---|---|
| Visit Week | Mean(SD) | Mean(SD) | Effect Size (SC-TAU) |
| ASI Drug Use | |||
| Baseline | 0.18(0.11) | 0.19(0.12) | −0.07 (−0.35,0.21) |
| Week 8 | 0.15(0.10) | 0.18(0.13) | −0.22 (−0.53,0.09) |
| Week 13 | 0.15(0.11) | 0.16(0.13) | −0.08 (−0.38,0.22) |
| Week 26 | 0.14(0.11) | 0.14(0.12) | 0.04 (−0.28,0.36) |
| ASI Medical | |||
| Baseline | 0.34(0.35) | 0.34(0.36) | 0.01 (−0.27,0.30) |
| Week 8 | 0.24(0.31) | 0.32(0.36) | −0.24 (−0.55,0.07) |
| Week 13 | 0.28(0.33) | 0.29(0.36) | −0.02 (−0.32,0.29) |
| Week 26 | 0.31(0.35) | 0.31(0.38) | −0.01 (−0.33,0.31) |
| ASI Psychological | |||
| Baseline | 0.25(0.24) | 0.24(0.25) | 0.05 (−0.24,0.33) |
| Week 8 | 0.20(0.23) | 0.19(0.24) | 0.05 (−0.26,0.35) |
| Week 13 | 0.22(0.24) | 0.17(0.22) | 0.23 (−0.07,0.53) |
| Week 26 | 0.20(0.23) | 0.20(0.23) | 0.01 (−0.31,0.34) |
*
Values in the table are the mean (with standard deviation) of the composite scores of patients in each category, plus the effect size between groups.